Prot# H6Q-MC-JCBJ(b): PRELUDE: A Phase 3 Clinical Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin

Project: Research project

Project Details

StatusFinished
Effective start/end date7/31/072/1/12

Funding

  • Eli Lilly and Company (H6Q-MC-JCBJ(b): PRELUDE)